Grizzlyrock Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMN Healthcare
AMN
|
+$2.13M |
| 2 |
Tidewater
TDW
|
+$1.51M |
| 3 |
Caesars Entertainment
CZR
|
+$1.36M |
| 4 |
Green Plains
GPRE
|
+$1.13M |
| 5 |
Xperi
XPER
|
+$1.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pathward Financial
CASH
|
+$7.44M |
| 2 |
Calumet Specialty Products
CLMT
|
+$6.64M |
| 3 |
Ecovyst
ECVT
|
+$3.29M |
| 4 |
SWI
SolarWinds Corporation Common Stock
SWI
|
+$1.81M |
| 5 |
Magnachip Semiconductor
MX
|
+$1.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 30% |
| 2 | Consumer Discretionary | 28.62% |
| 3 | Communication Services | 14.36% |
| 4 | Technology | 9.55% |
| 5 | Healthcare | 9.33% |
Similar funds
Grizzlyrock Capital's Q4 2024 Portfolio in Review
As of Q4 2024, Grizzlyrock Capital held 21 positions worth $95.8M, down 17% from $116M the previous quarter. Its ten largest holdings account for 89% of the portfolio.
Grizzlyrock Capital withdrew a net $15.2M in Q4 2024, closing 4 positions and reducing 5 holdings. Its most notable exit was Calumet Specialty Products, an estimated $6.64M position sold in full.
By sector, the portfolio is most concentrated in Materials at 30% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Grizzlyrock Capital opened a new position in AMN Healthcare worth $1.6M.
- Grizzlyrock Capital's largest Q4 2024 buy was AMN Healthcare: 66,900 shares worth $1.6M.
- Grizzlyrock Capital added most to Caesars Entertainment in Q4 2024, an estimated $1.36M increase.
- Grizzlyrock Capital's biggest Q4 2024 reduction was Pathward Financial, cutting an estimated $7.44M.
- Grizzlyrock Capital fully exited Calumet Specialty Products in Q4 2024, selling an estimated $6.64M.
- Grizzlyrock Capital's ten largest holdings make up 89% of its $95.8M portfolio in Q4 2024.
- Grizzlyrock Capital opened 3 new positions and closed 4 in Q4 2024.
- Grizzlyrock Capital's portfolio value fell 17% quarter-over-quarter to $95.8M.
Based on Grizzlyrock Capital's 13F filing for Q4 2024, filed 14 Feb 2025.